Regeneron Pharmaceuticals Inc (REGN)
Financial leverage ratio
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 33,080,200 | 32,163,300 | 30,657,500 | 30,059,900 | 29,214,500 | 27,677,800 | 27,205,800 | 26,348,700 | 25,434,800 | 23,671,500 | 21,485,900 | 17,772,200 | 17,163,300 | 16,084,000 | 14,428,700 | 15,757,500 | 14,805,200 | 13,939,300 | 13,173,600 | 12,854,800 |
Total stockholders’ equity | US$ in thousands | 25,973,100 | 24,904,400 | 24,017,900 | 23,495,200 | 22,664,000 | 21,438,800 | 20,687,800 | 19,914,700 | 18,768,800 | 17,258,000 | 15,127,300 | 11,977,000 | 11,025,300 | 10,125,500 | 9,057,400 | 12,133,000 | 11,089,700 | 10,504,400 | 9,755,900 | 9,444,700 |
Financial leverage ratio | 1.27 | 1.29 | 1.28 | 1.28 | 1.29 | 1.29 | 1.32 | 1.32 | 1.36 | 1.37 | 1.42 | 1.48 | 1.56 | 1.59 | 1.59 | 1.30 | 1.34 | 1.33 | 1.35 | 1.36 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $33,080,200K ÷ $25,973,100K
= 1.27
Regeneron Pharmaceuticals, Inc.'s financial leverage ratio has remained relatively stable over the past eight quarters, fluctuating between 1.27 and 1.32. The financial leverage ratio measures the extent to which a company utilizes debt to finance its operations and growth. A ratio above 1 indicates that the company has more debt than equity in its capital structure.
Regeneron's financial leverage ratio of around 1.28 to 1.32 suggests that the company relies moderately on debt financing to support its business activities. The consistency in the ratio over the quarters indicates a balanced approach to leveraging, neither excessively relying on debt nor being overly conservative.
Staying within this range of financial leverage ratios can be considered favorable as it signifies that Regeneron has a relatively stable capital structure with a manageable level of debt. However, it is essential for the company to monitor and manage its debt levels effectively to ensure long-term financial health and sustainability.
Peer comparison
Dec 31, 2023
See also:
Regeneron Pharmaceuticals Inc Financial Leverage (Quarterly Data)